SCTX (Scribe Therapeutics) Marketable Securities: $29.35 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCTX Scribe Therapeutics Inc SCTX
8 GF Score
Price $22.00
View Full Analysis

What is Scribe Therapeutics Marketable Securities?

Scribe Therapeutics SCTX -13.40% 8 Marketable Securities is $29.35 Mil as of Mar. 2026. GuruFocus rates SCTX with a GF Score™ of 8/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Scribe Therapeutics's Marketable Securities for the quarter that ended in Mar. 2026 was $29.35 Mil.

Scribe Therapeutics's annual Marketable Securities increased from . 20 ($0.00 Mil) to Dec. 2024 ($92.57 Mil) but then declined from Dec. 2024 ($92.57 Mil) to Dec. 2025 ($45.17 Mil).

Scribe Therapeutics  (NAS:SCTX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Scribe Therapeutics Marketable Securities Related Terms

Scribe Therapeutics Marketable Securities Historical Data

* Premium members only.

The historical data trend for Scribe Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scribe Therapeutics Marketable Securities Chart

Scribe Therapeutics Annual Data
Trend Dec24 Dec25
Marketable Securities
92.57 45.17

Scribe Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
Marketable Securities 92.57 0.00 45.17 29.35
SCTX
8GF Score
Scribe Therapeutics Inc SCTX
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scribe Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $29.35 Mil mean?
Scribe Therapeutics (SCTX) has a Marketable Securities of $29.35 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Scribe Therapeutics and its competitors.
Is Scribe Therapeutics' Marketable Securities too high?
Scribe Therapeutics' current Marketable Securities is $29.35 Mil. Overall, Scribe Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scribe Therapeutics' Marketable Securities compare to ?
Scribe Therapeutics' Marketable Securities of $29.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Scribe Therapeutics and its competitors. Scribe Therapeutics's current Marketable Securities is $29.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scribe Therapeutics stock overvalued right now?
Scribe Therapeutics (SCTX) has a current Marketable Securities of $29.35 Mil. The current Marketable Securities is $29.35 Mil. Scribe Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Scribe Therapeutics (SCTX), the current Marketable Securities is $29.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scribe Therapeutics Business Description

Comparable Companies
Address 1150 Marina Village Parkway, Alameda, CA, USA, 94501
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
8GF Score

Get the complete analysis for SCTX

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price